We are live on ! Find out more
DXTR

Dextera Surgical Inc.
DXTR

Delisted

DXTR was delisted on the 12th of December, 2017.

20 hedge funds and large institutions have $4.35M invested in Dextera Surgical Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

46% more capital invested

Capital invested by funds: $2.98M → $4.35M (+$1.37M)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

9% less funds holding

Funds holding: 2220 (-2)

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

DXTR Hedge Fund Activity: Q1 2017 in Review

20 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Dextera Surgical Inc. (DXTR) for Q1 2017, worth a combined $4.35M — up 46% from $2.98M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new DXTR positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $185K. The largest seller was Sabby Management, exiting entirely with an estimated $382K sold.

  • 20 institutional investors held Dextera Surgical Inc. (DXTR) as of Q1 2017, down from 22 in Q4 2016.
  • Funds reported $4.35M of Dextera Surgical Inc. stock for Q1 2017, up 46% quarter-over-quarter.
  • 5 funds opened new Dextera Surgical Inc. positions in Q1 2017 and 3 closed out, a net change of +2 holders.
  • The largest Dextera Surgical Inc. buyer in Q1 2017 was Vanguard Group, an estimated $185K added.
  • The largest Dextera Surgical Inc. seller in Q1 2017 was Sabby Management, an estimated $382K sold.

Based on aggregated 13F filings for Q1 2017.